BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations

  May 14, 2025

   · 

  10 min read
• Press Releases

  Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

  May 14, 2025

   · 

  7 min read
• Press Releases

  Foghorn Therapeutics Provides First Quarter 2025 Financial and Corporate Update

  May 14, 2025

   · 

  12 min read
• Press Releases

  Emergent BioSolutions to Participate in Upcoming Investor Conferences

  May 14, 2025

   · 

  1 min read
• Press Releases

  Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2025

  May 14, 2025

   · 

  1 min read
• Press Releases

  Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

  May 14, 2025

   · 

  4 min read
• Press Releases

  Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD

  May 14, 2025

   · 

  8 min read
• Press Releases

  Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates

  May 14, 2025

   · 

  3 min read
• Press Releases

  Kura Oncology and Kyowa Kirin Announce Combination Data for Ziftomenib in Oral Presentation at the 2025 European Hematology Association (EHA) Congress

  May 14, 2025

   · 

  6 min read
• Press Releases

  Genmab to Present New and Updated Results from its Robust Epcoritamab (EPKINLY®) Development Program at the 2025 European Hematology Association (EHA) Congress

  May 14, 2025

   · 

  13 min read